Home » Topics » BioWorld Science

BioWorld Science
RSS

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Jan. 19, 2021

Shanghai Institute of Materia Medica dicloses new hepatitis B virus inhibitors

Jan. 19, 2021

LCP2 is a therapeutic target in lethal sepsis

Jan. 19, 2021

Sobetirome and its prodrug show efficacy in models of EAE

Jan. 19, 2021

Murine model of SARS-CoV-2 infection developed via mRNA transfection of hACE2

Jan. 19, 2021

Enrollment opens in phase II study of vactosertib plus pembrolizumab in NSCLC

Jan. 19, 2021

Eli Lilly initiates phase II study of LY-3462817 in rheumatoid arthritis

Jan. 19, 2021

First patient dosed in phase II study of alisporivir in early-stage COVID-19

Jan. 19, 2021

Biohaven presents focused analysis data from phase II/III study of troriluzole in AD

Jan. 19, 2021

Grifols to begin clinical evaluation of new COVID-19 treatment

Jan. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...